Greer Monte A, Goodman Gay, Pleus Richard C, Greer Susan E
Oregon Health & Science University, Portland, Oregon, USA.
Environ Health Perspect. 2002 Sep;110(9):927-37. doi: 10.1289/ehp.02110927.
Application of a sensitive new detection method has revealed widespread perchlorate contamination of groundwater in the southwestern United States, typically at 0.005-0.020 mg/L (5-20 ppb). Perchlorate is a competitive inhibitor of the process by which iodide is actively transported from the bloodstream into the thyroid. This inhibitory action of perchlorate is the basis of its pharmaceutical use (in the treatment of hyperthyroidism) as well as its potential toxicity. To establish the dose response in humans for perchlorate inhibition of thyroidal iodide uptake and any short-term effects on thyroid hormones, we gave perchlorate in drinking water at 0.007, 0.02, 0.1, or 0.5 mg/kg-day to 37 male and female volunteers for 14 days. In 24 subjects we performed 8- and 24-hr measurements of thyroidal (123)I uptake (RAIU) before exposure, on exposure days 2 (E2) and 14 (E14), and 15 days postexposure (P15). In another 13 subjects we omitted both E2 studies and the 8-hr P15 study. We observed a strong correlation between the 8- and 24-hr RAIU over all dose groups and measurement days. We found no difference between E2 and E14 in the inhibition of RAIU produced by a given perchlorate dose. We also found no sex difference. On both E2 and E14, the dose response was a negative linear function of the logarithm of dose. Based on the dose response for inhibition of the 8- and 24-hr RAIU on E14 in all subjects, we derived estimates of the true no-effect level: 5.2 and 6.4 micro g/kg-day, respectively. Given default body weight and exposure assumptions, these doses would be ingested by an adult if the drinking-water supply contained perchlorate at concentrations of approximately 180 and 220 micro g/L (ppb), respectively. On P15, RAIU was not significantly different from baseline. In 24 subjects we measured serum levels of thyroxine (total and free), triiodothyronine, and thyrotropin in blood sampled 16 times throughout the study. Only the 0.5 mg/kg-day dose group showed any effect on serum hormones: a slight downward trend in thyrotropin levels in morning blood draws during perchlorate exposure, with recovery by P15.
一种灵敏的新检测方法的应用揭示了美国西南部地下水中普遍存在高氯酸盐污染,其浓度通常为0.005 - 0.020毫克/升(5 - 20 ppb)。高氯酸盐是碘从血液主动转运至甲状腺这一过程的竞争性抑制剂。高氯酸盐的这种抑制作用是其药用(用于治疗甲状腺功能亢进)以及潜在毒性的基础。为确定高氯酸盐对甲状腺碘摄取的抑制作用在人体中的剂量反应以及对甲状腺激素的任何短期影响,我们让37名男性和女性志愿者连续14天饮用含0.007、0.02、0.1或0.5毫克/千克·天高氯酸盐的水。在24名受试者中,我们在暴露前、暴露第2天(E2)和第14天(E14)以及暴露后15天(P15)进行了8小时和24小时的甲状腺(123)I摄取(RAIU)测量。在另外13名受试者中,我们省略了E2研究和8小时的P15研究。我们观察到在所有剂量组和测量天数中,8小时和24小时的RAIU之间存在很强的相关性。我们发现给定高氯酸盐剂量对RAIU的抑制作用在E2和E14之间没有差异。我们也未发现性别差异。在E2和E14时,剂量反应都是剂量对数的负线性函数。根据所有受试者在E14时对8小时和24小时RAIU抑制作用的剂量反应,我们得出了真实无效应水平的估计值:分别为5.2和6.4微克/千克·天。基于默认的体重和暴露假设,如果饮用水供应中高氯酸盐浓度分别约为180和220微克/升(ppb),成年人会摄入这些剂量。在P15时,RAIU与基线无显著差异。在24名受试者中,我们在整个研究过程中16次采集血液样本,测量血清中的甲状腺素(总甲状腺素和游离甲状腺素)、三碘甲状腺原氨酸和促甲状腺激素水平。只有0.5毫克/千克·天剂量组对血清激素有任何影响:在高氯酸盐暴露期间早晨采血时促甲状腺激素水平有轻微下降趋势,到P15时恢复。